Global Anti-Obesity Drugs Market Research Report 2018-2025 | Pfizer, Merck, GlaxoSmithKline, AstraZeneca

visionresearchreports.com adds “Global Anti-Obesity Drugs Market Research Report 2018” new report to its research database.

This report studies the global Anti-Obesity Drugs market status and forecast, categorizes the global Anti-Obesity Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

The major manufacturers covered in this report
Pfizer
Merck
F.Hoffmann-La Roche
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Novo Nordisk
Eisai
Norgine
Arena Pharmaceuticals
Orexigen Therapeutics
Vivus
Alizyme
Rhythm Pharmaceuticals
Shionogi
Zafgan

Get Sample Copy Of This Report @ https://www.visionresearchreports.com/report/sample/464

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Prescription Drugs
OTC drugs
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
6-18 Callant
18-30 Adult
30-60Middle-Aged
Others

The study objectives of this report are:
To analyze and study the global Anti-Obesity Drugs capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Anti-Obesity Drugs manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Anti-Obesity Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Anti-Obesity Drugs Manufacturers
Anti-Obesity Drugs Distributors/Traders/Wholesalers
Anti-Obesity Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Anti-Obesity Drugs market, by end-use.
Detailed analysis and profiles of additional market players

View Complete Report @ https://www.visionresearchreports.com/anti-obesity-drugs-market/464

Table of Contents

Global Anti-Obesity Drugs Market Research Report 2018
1 Anti-Obesity Drugs Market Overview
1.1 Product Overview and Scope of Anti-Obesity Drugs
1.2 Anti-Obesity Drugs Segment by Type (Product Category)
1.2.1 Global Anti-Obesity Drugs Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Anti-Obesity Drugs Production Market Share by Type (Product Category) in 2017
1.2.3 Prescription Drugs
1.2.3 OTC drugs
1.3 Global Anti-Obesity Drugs Segment by Application
1.3.1 Anti-Obesity Drugs Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 6-18 Callant
1.3.3 18-30 Adult
1.3.4 30-60Middle-Aged
1.3.5 Others
1.4 Global Anti-Obesity Drugs Market by Region (2013-2025)
1.4.1 Global Anti-Obesity Drugs Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Anti-Obesity Drugs (2013-2025)
1.5.1 Global Anti-Obesity Drugs Revenue Status and Outlook (2013-2025)
1.5.2 Global Anti-Obesity Drugs Capacity, Production Status and Outlook (2013-2025)

2 Global Anti-Obesity Drugs Market Competition by Manufacturers
2.1 Global Anti-Obesity Drugs Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Anti-Obesity Drugs Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Anti-Obesity Drugs Production and Share by Manufacturers (2013-2018)
2.2 Global Anti-Obesity Drugs Revenue and Share by Manufacturers (2013-2018)
2.3 Global Anti-Obesity Drugs Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Anti-Obesity Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Anti-Obesity Drugs Market Competitive Situation and Trends
2.5.1 Anti-Obesity Drugs Market Concentration Rate
2.5.2 Anti-Obesity Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Anti-Obesity Drugs Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Anti-Obesity Drugs Capacity and Market Share by Region (2013-2018)
3.2 Global Anti-Obesity Drugs Production and Market Share by Region (2013-2018)
3.3 Global Anti-Obesity Drugs Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Anti-Obesity Drugs Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Anti-Obesity Drugs Consumption by Region (2013-2018)
4.2 North America Anti-Obesity Drugs Production, Consumption, Export, Import (2013-2018)
4.3 Europe Anti-Obesity Drugs Production, Consumption, Export, Import (2013-2018)
4.4 China Anti-Obesity Drugs Production, Consumption, Export, Import (2013-2018)
4.5 Japan Anti-Obesity Drugs Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Anti-Obesity Drugs Production, Consumption, Export, Import (2013-2018)
4.7 India Anti-Obesity Drugs Production, Consumption, Export, Import (2013-2018)

5 Global Anti-Obesity Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Anti-Obesity Drugs Production and Market Share by Type (2013-2018)
5.2 Global Anti-Obesity Drugs Revenue and Market Share by Type (2013-2018)
5.3 Global Anti-Obesity Drugs Price by Type (2013-2018)
5.4 Global Anti-Obesity Drugs Production Growth by Type (2013-2018)

6 Global Anti-Obesity Drugs Market Analysis by Application
6.1 Global Anti-Obesity Drugs Consumption and Market Share by Application (2013-2018)
6.2 Global Anti-Obesity Drugs Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Anti-Obesity Drugs Manufacturers Profiles/Analysis
7.1 Pfizer
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Anti-Obesity Drugs Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Pfizer Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Merck
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Anti-Obesity Drugs Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Merck Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 F.Hoffmann-La Roche
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Anti-Obesity Drugs Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 F.Hoffmann-La Roche Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 GlaxoSmithKline
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Anti-Obesity Drugs Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 GlaxoSmithKline Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 AstraZeneca
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Anti-Obesity Drugs Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 AstraZeneca Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 Boehringer Ingelheim
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Anti-Obesity Drugs Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Boehringer Ingelheim Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Novo Nordisk
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Anti-Obesity Drugs Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Novo Nordisk Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Eisai
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Anti-Obesity Drugs Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Eisai Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Norgine
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Anti-Obesity Drugs Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Norgine Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.8 Arena Pharmaceuticals
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Anti-Obesity Drugs Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Arena Pharmaceuticals Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview
7.11 Orexigen Therapeutics
7.12 Vivus
7.13 Alizyme
7.14 Rhythm Pharmaceuticals
7.15 Shionogi
7.16 Zafgan

8 Anti-Obesity Drugs Manufacturing Cost Analysis
8.1 Anti-Obesity Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Anti-Obesity Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Anti-Obesity Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Anti-Obesity Drugs Major Manufacturers in 2017
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Anti-Obesity Drugs Market Forecast (2018-2025)
12.1 Global Anti-Obesity Drugs Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Anti-Obesity Drugs Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Anti-Obesity Drugs Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Anti-Obesity Drugs Price and Trend Forecast (2018-2025)
12.2 Global Anti-Obesity Drugs Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Anti-Obesity Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Anti-Obesity Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Anti-Obesity Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Anti-Obesity Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Anti-Obesity Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Anti-Obesity Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Anti-Obesity Drugs Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Anti-Obesity Drugs Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer

Request To Buy This Premium Report @ https://www.visionresearchreports.com/report/cart/464

About Us

Vision Research Reports is unquestionably an expert in providing research reports on a diverse number of subjects including Alternative and Green Energy, Chemical, Energy, Glass, Machinery, Manufacturing, and Pharmaceuticals and Materials. We cater to distinguished MNCs, private equity firms, SMEs and Chinese companies pertaining to their market research data requirements.

Contact Us

Sai Krupa
Office no.1, shivneri nagar,
kondhwa Khurd,
Pune 411048

This release was published on openPR.